Bilirubin Meter Market: Current Analysis and Forecast (2022-2028)

Bilirubin meters are devices designed for the measurement of the concentration of bilirubin present in the blood or clinical specimen there are several types of bilirubin meters, including those that use spectroscopy, turbidity and impedance. The level of bilirubin should be interpreted in conjunction with other laboratory results and clinical findings. A high level of bilirubin can be a sign of a number of conditions including haemolytic anaemia, liver disease and neonatal jaundice. On the contrary, lower levels of bilirubin may be seen in patients taking antibiotics or may be due to other medical conditions including Gilbert's syndrome.

The bilirubin meter Market is anticipated to grow with a CAGR of 6% in the forecasted period. The diagnostic tools for the identification of neonatal jaundice. This is attributed to the rising incidence of jaundice amongst the neonates along with those neonates who are born before 8 weeks. For instance, according to the national health service 2022 report, around 6 out of 10 babies born develop jaundice including 8 out of 10 who are born prematurely before 37 weeks of pregnancy. Additionally, the risk factors associated with the development of jaundice include instrumental deliveries, induction of labour with oxytocin, infant bursting and other medical conditions. Thus, all these factors are anticipated to fuel the market growth in the forecast period.

Based on the product, the market is bifurcated into portable bilirubinometers and benchtop bilirubinometers. Amongst these, the portable bilirubinometer is anticipated to grow with a significant CAGR in the forecasted period. These are typically small and lightweight, making them easy to carry and use in a variety of settings, including hospitals, clinics, and home care settings. They use a small amount of blood, typically from a fingertip or heel stick, to measure the level of bilirubin. Thus, this factor is contributing towards the growth of this segment.

Based on end-users the market is segmented into hospitals, clinics and research institutes. Amongst these, the hospital segment is anticipated to grow with a significant CAGR in the forecasted period. Hospitals play a crucial role in the early detection and management of liver disease, including jaundice and hepatitis which can help prevent severe complications of diseases. Additionally, hospitals are equipped with the necessary medical equipment and staff to provide comprehensive care to patients with a wide range of medical conditions and reduce the overall burden of the disease on the healthcare system. These elements are driving the demand for the hospitals

For a better understanding of the market adoption of the Behavior Health industry, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, and the Rest of North America), Europe (UK, Germany, France, Italy, Spain and Rest of Europe), Asia-Pacific (China, Japan, India, South Korea, and Rest of Asia-Pacific), Rest of World. Asia-pacific is anticipated to grow with a significant CAGR during the forecasted period. This is attributed to the increase in healthcare expenditure in this region. For instance, healthcare expenditures paid to medical institutions in fiscal 2021 reached a record USD 316 trillion, an increase of 14 trillion, or 4.6%, compared to the previous year. This is propelling the market growth in this region.

Some of the major players operating in the market include: Advanced Instruments Inc., APEL Co., Ltd., Siemens Medical Solutions USA, Inc., Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Dragerwerk AG & Co. KGaA, Zhengzhou Dison Instrument and Meter Co., ltd. , Mennen Medical, Natus Medical Incorporated., DAVID, Micro Lab Instruments.